Top 4 NASDAQ Stocks In The Biotechnology Industry With The Lowest PEG Ratio

by Monica Gerson, Benzinga Staff Writer

July 10, 2014 4:51 AM | 28 seconds read | Make a Comment

Below are the top biotechnology stocks on the NASDAQ in terms of PEG ratio. Aratana Therapeutics

PETX

has a PEG ratio of 0.30. Aratana Therapeutics' trailing-twelve-month revenue is $0.30 million. Enzymotec

ENZY

has a PEG ratio of 0.36. Enzymotec's trailing-twelve-month profit margin is 13.90%. PDL BioPharma

PDLI

has a PEG ratio of 0.39. PDL BioPharma's trailing-twelve-month EPS is $1.78. Questcor Pharmaceuticals

QCOR

has a PEG ratio of 0.61. Questcor's trailing-twelve-month ROE is 86.50%.

Posted In: Trading Ideas Biotechnology Industry NASDAQ PEG ratio

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.